T A D Q I Q O T L A R
jahon ilmiy – metodik jurnali
https://scientific-jl.com
60-son_1-to’plam_Aprel-2025
183
ISSN:3030-3613
RECURRENT APHTHOUS STOMATITIS
Teshayeva Nozigul Ҳамидулло қизи
Bukhara State Medical Institute named after Abu Ali Ibn Sino
Tel : +998911329697
Nozigulteshayeva
@gmail.com
ABSTRACT
.
Recurrent aphthous stomatitis (RAS), commonly called "canker
sores," is a perplexing oral condition characterized by the recurrent development of
painful aphthous ulcers on non-keratinized oral mucous membranes. This condition
poses a significant challenge to patients and healthcare professionals due to its
uncertain etiology. Patients often report a family history of RAS, suggesting a genetic
predisposition. Factors such as local trauma, stress, smoking cessation, anemia, and
hematinic deficiency have also been linked to the occurrence of RAS. Gastrointestinal
conditions like Crohn's disease, ulcerative colitis, and malabsorption diseases,
including celiac disease, are associated with the development of oral aphthous ulcers.
RAS is a possible clinical manifestation of more severe conditions like Behçet's disease
or HIV infection, making early diagnosis and management critical.
This activity offers a comprehensive review of the evaluation and treatment of
recurrent aphthous stomatitis, providing healthcare professionals with the latest
insights into this enigmatic condition. Participants will explore the diagnostic process,
which relies on a thorough medical history and clinical findings. The program also
delves into the various treatment modalities for RAS, emphasizing topical
corticosteroids as the first-line approach and systemic steroids for more severe cases.
Additionally, the use of immunosuppressants to prevent the formation of new RAS
lesions and reduce the adverse effects associated with systemic steroids will be
discussed. By participating in this activity, healthcare providers will gain a deeper
understanding of RAS and its management, allowing them to provide more effective
care for patients afflicted with this challenging condition.
Objectives:
Identify the etiology and predisposing factors of recurrent aphthous
stomatitis.
Identify the typical examination findings of aphthous stomatitis.
Assess the management considerations for patients with aphthous
stomatitis.
Compare differential diagnoses of recurrent aphthous stomatitis.
Introduction
Recurrent aphthous stomatitis (RAS) is a chronic oral mucosa inflammatory
disorder with an uncertain etiology.[1] Diagnosis is based on medical history and
T A D Q I Q O T L A R
jahon ilmiy – metodik jurnali
https://scientific-jl.com
60-son_1-to’plam_Aprel-2025
184
ISSN:3030-3613
clinical findings. There seems to be a genetic predisposition to the condition, as up to
46% of patients report a family history of RAS.[2] Certain factors predispose to RAS,
including local trauma, stress, smoking cessation, anemia, and hematinic deficiency.[3]
Gastrointestinal conditions such as Chron disease, ulcerative colitis, and malabsorption
diseases like celiac disease are also linked to the development of oral aphthous ulcers.
Furthermore, RAS characterizes Behçet disease, and atypically severe RAS
presentation may be a sign of HIV infection. Topical corticosteroids are the first line
of treatment for managing RAS.[2][4] A short course of systemic steroids is reserved
for more severe cases. Immunosuppressants are sometimes indicated to prevent the
formation of new RAS lesions and decrease the prevalence of adverse effects
experienced with systemic steroids
.
REFERENCES
1.
Sánchez-Bernal J, Conejero C, Conejero R. Recurrent Aphthous Stomatitis. Actas
Dermosifiliogr (Engl Ed). 2020 Jul-Aug;111(6):471-480. [PubMed]
2.
Chiang CP, Yu-Fong Chang J, Wang YP, Wu YH, Wu YC, Sun A. Recurrent
aphthous stomatitis - Etiology, serum autoantibodies, anemia, hematinic
deficiencies, and management. J Formos Med Assoc. 2019 Sep;118(9):1279-1289.
[PubMed]
3.
Scully C, Porter S. Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral
Maxillofac Surg. 2008 Apr;46(3):198-206. [PubMed]
4.
Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent
aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003
Feb;134(2):200-7. [PubMed]
5.
Mimura MA, Hirota SK, Sugaya NN, Sanches JA, Migliari DA. Systemic treatment
in severe cases of recurrent aphthous stomatitis: an open trial. Clinics (Sao Paulo).
2009;64(3):193-8. [PMC free article] [PubMed]
6.
Savage NW, Seymour GJ, Kruger BJ. Expression of class I and class II major
histocompatibility complex antigens on epithelial cells in recurrent aphthous
stomatitis. J Oral Pathol. 1986 Apr;15(4):191-5. [PubMed]
7.
Hasan A, Childerstone A, Pervin K, Shinnick T, Mizushima Y, Van der Zee R,
Vaughan R, Lehner T. Recognition of a unique peptide epitope of the mycobacterial
and human heat shock protein 65-60 antigen by T cells of patients with recurrent
oral ulcers. Clin Exp Immunol. 1995 Mar;99(3):392-7. [PMC free article]
[PubMed]
8.
Shohat-Zabarski R, Kalderon S, Klein T, Weinberger A. Close association of HLA-
B51 in persons with recurrent aphthous stomatitis. Oral Surg Oral Med Oral Pathol.
1992 Oct;74(4):455-8. [PubMed]
9.
Bazrafshani MR, Hajeer AH, Ollier WE, Thornhill MH. Recurrent aphthous
stomatitis and gene polymorphisms for the inflammatory markers TNF-alpha, TNF-
T A D Q I Q O T L A R
jahon ilmiy – metodik jurnali
https://scientific-jl.com
60-son_1-to’plam_Aprel-2025
185
ISSN:3030-3613
beta and the vitamin D receptor: no association detected. Oral Dis. 2002
Nov;8(6):303-7. [PubMed]
10.
Mizuki N, Ohno S, Sato T, Ishihara M, Miyata S, Nakamura S, Naruse T, Mizuki
H, Tsuji K, Inoko H. Microsatellite polymorphism between the tumor necrosis
factor and HLA-B genes in Behçet's disease. Hum Immunol. 1995 Jun;43(2):129-
35. [PubMed]
11.
Huling LB, Baccaglini L, Choquette L, Feinn RS, Lalla RV. Effect of stressful life
events on the onset and duration of recurrent aphthous stomatitis. J Oral Pathol Med.
2012 Feb;41(2):149-52. [PMC free article] [PubMed]
